176 related articles for article (PubMed ID: 31053636)
1. Lifetime Occurrence of Brain Metastases Arising from Lung, Breast, and Skin Cancers in the Elderly: A SEER-Medicare Study.
Ascha MS; Ostrom QT; Wright J; Kumthekar P; Bordeaux JS; Sloan AE; Schumacher FR; Kruchko C; Barnholtz-Sloan JS
Cancer Epidemiol Biomarkers Prev; 2019 May; 28(5):917-925. PubMed ID: 31053636
[TBL] [Abstract][Full Text] [Related]
2. Estimating the annual frequency of synchronous brain metastasis in the United States 2010-2013: a population-based study.
Kromer C; Xu J; Ostrom QT; Gittleman H; Kruchko C; Sawaya R; Barnholtz-Sloan JS
J Neurooncol; 2017 Aug; 134(1):55-64. PubMed ID: 28567587
[TBL] [Abstract][Full Text] [Related]
3. Incidence proportions of brain metastases in patients diagnosed (1973 to 2001) in the Metropolitan Detroit Cancer Surveillance System.
Barnholtz-Sloan JS; Sloan AE; Davis FG; Vigneau FD; Lai P; Sawaya RE
J Clin Oncol; 2004 Jul; 22(14):2865-72. PubMed ID: 15254054
[TBL] [Abstract][Full Text] [Related]
4. Disparities in the use of stereotactic radiosurgery for the treatment of lung cancer brain metastases: a SEER-Medicare study.
Ascha MS; Funk K; Sloan AE; Kruchko C; Barnholtz-Sloan JS
Clin Exp Metastasis; 2020 Feb; 37(1):85-93. PubMed ID: 31705229
[TBL] [Abstract][Full Text] [Related]
5. Risk of brain metastases in patients with nonmetastatic lung cancer: Analysis of the Metropolitan Detroit Surveillance, Epidemiology, and End Results (SEER) data.
Goncalves PH; Peterson SL; Vigneau FD; Shore RD; Quarshie WO; Islam K; Schwartz AG; Wozniak AJ; Gadgeel SM
Cancer; 2016 Jun; 122(12):1921-7. PubMed ID: 27062154
[TBL] [Abstract][Full Text] [Related]
6. Factors for incidence risk and prognosis in non-small-cell lung cancer patients with synchronous brain metastasis: a population-based study.
Zhu H; Zhou L; Guo Y; Yang G; Dong Q; Zhang Z; Chen M; Yang Q
Future Oncol; 2021 Jul; 17(19):2461-2473. PubMed ID: 33706557
[TBL] [Abstract][Full Text] [Related]
7. Measuring the incidence of cancer in elderly Americans using Medicare claims data.
McBean AM; Warren JL; Babish JD
Cancer; 1994 May; 73(9):2417-25. PubMed ID: 8168045
[TBL] [Abstract][Full Text] [Related]
8. Comparison of Comorbid Medical Conditions in the National Cancer Database and the SEER-Medicare Database.
Lin CC; Virgo KS; Robbins AS; Jemal A; Ward EM
Ann Surg Oncol; 2016 Dec; 23(13):4139-4148. PubMed ID: 27535406
[TBL] [Abstract][Full Text] [Related]
9. Determination of lung cancer incidence in the elderly using Medicare claims data.
McBean AM; Babish JD; Warren JL
Am J Epidemiol; 1993 Jan; 137(2):226-34. PubMed ID: 8452127
[TBL] [Abstract][Full Text] [Related]
10. Incidence of brain metastases in a cohort of patients with carcinoma of the breast, colon, kidney, and lung and melanoma.
Schouten LJ; Rutten J; Huveneers HA; Twijnstra A
Cancer; 2002 May; 94(10):2698-705. PubMed ID: 12173339
[TBL] [Abstract][Full Text] [Related]
11. Population-based estimates of survival among elderly patients with brain metastases.
Lamba N; Kearney RB; Catalano PJ; Hassett MJ; Wen PY; Haas-Kogan DA; Aizer AA
Neuro Oncol; 2021 Apr; 23(4):661-676. PubMed ID: 33068418
[TBL] [Abstract][Full Text] [Related]
12. Predictors of prognosis of synchronous brain metastases in small-cell lung cancer patients.
Reddy SP; Dowell JE; Pan E
Clin Exp Metastasis; 2020 Aug; 37(4):531-539. PubMed ID: 32500410
[TBL] [Abstract][Full Text] [Related]
13. Limited validity of diagnosis codes in Medicare claims for identifying cancer metastases and inferring stage.
Chawla N; Yabroff KR; Mariotto A; McNeel TS; Schrag D; Warren JL
Ann Epidemiol; 2014 Sep; 24(9):666-72, 672.e1-2. PubMed ID: 25066409
[TBL] [Abstract][Full Text] [Related]
14. Brain Metastases among Cancer Patients Diagnosed from 2010-2017 in Canada: Incidence Proportion at Diagnosis and Estimated Lifetime Incidence.
Liu JL; Walker EV; Paudel YR; Davis FG; Yuan Y
Curr Oncol; 2022 Mar; 29(3):2091-2105. PubMed ID: 35323369
[TBL] [Abstract][Full Text] [Related]
15. Cancer prevalence estimates based on tumour registry data in the Surveillance, Epidemiology, and End Results (SEER) Program.
Merrill RM; Capocaccia R; Feuer EJ; Mariotto A
Int J Epidemiol; 2000 Apr; 29(2):197-207. PubMed ID: 10817114
[TBL] [Abstract][Full Text] [Related]
16. Brain Metastases in Newly Diagnosed Breast Cancer: A Population-Based Study.
Martin AM; Cagney DN; Catalano PJ; Warren LE; Bellon JR; Punglia RS; Claus EB; Lee EQ; Wen PY; Haas-Kogan DA; Alexander BM; Lin NU; Aizer AA
JAMA Oncol; 2017 Aug; 3(8):1069-1077. PubMed ID: 28301662
[TBL] [Abstract][Full Text] [Related]
17. Epidemiological trends, prognostic factors, and survival outcomes of synchronous brain metastases from 2015 to 2019: a population-based study.
Parker M; Jiang K; Rincon-Torroella J; Materi J; Azad TD; Kamson DO; Kleinberg LR; Bettegowda C
Neurooncol Adv; 2023; 5(1):vdad015. PubMed ID: 36968289
[TBL] [Abstract][Full Text] [Related]
18. Accuracy of Medicare claims data for estimation of cancer incidence and resection rates among elderly Americans.
Whittle J; Steinberg EP; Anderson GF; Herbert R
Med Care; 1991 Dec; 29(12):1226-36. PubMed ID: 1745080
[TBL] [Abstract][Full Text] [Related]
19. Concordance between administrative claims and registry data for identifying metastasis to the bone: an exploratory analysis in prostate cancer.
Onukwugha E; Yong C; Hussain A; Seal B; Mullins CD
BMC Med Res Methodol; 2014 Jan; 14():1. PubMed ID: 24383436
[TBL] [Abstract][Full Text] [Related]
20. Risk factors, prognostic factors, and nomograms for bone metastasis in patients with newly diagnosed infiltrating duct carcinoma of the breast: a population-based study.
Huang Z; Hu C; Liu K; Yuan L; Li Y; Zhao C; Hu C
BMC Cancer; 2020 Nov; 20(1):1145. PubMed ID: 33238981
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
